Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Gonorrhea Figures

thumbnail of Figure 16Figure 16. Gonorrhea—Rates, United States, 1941–2011

thumbnail of Figure 17Figure 17. Gonorrhea—Rates by Sex, United States, 1991–2011

thumbnail of Figure 18Figure 18. Gonorrhea—Rates by Region, United States, 2002–2011

thumbnail of Figure 19Figure 19. Gonorrhea—Rates by State, United States and Outlying Areas, 2011

thumbnail of Figure 20Figure 20. Gonorrhea—Rates by County, United States, 2011

thumbnail of Figure 21Figure 21. Gonorrhea—Rates by Age and Sex, United States, 2011

thumbnail of Figure 22Figure 22. Gonorrhea—Rates by Age Among Women Aged 15–44 Years, United States, 2002–2011

thumbnail of Figure 23Figure 23. Gonorrhea—Rates by Age Among Men Aged 15–44 Years, United States, 2002–2011

thumbnail of Figure 24Figure 24. Gonorrhea—Rates by Race/Ethnicity, United States, 2002–2011

thumbnail of Figure 25Figure 25. Gonorrhea—Cases by Reporting Source and Sex, United States, 2002–2011

thumbnail of Figure 26Figure 26. Gonorrhea—Percentage of Reported Cases by Sex and Selected Reporting Sources, United States, 2011

thumbnail of Figure 27Figure 27. Proportion of MSM, MSW, and Women Among Interviewed Gonorrhea Cases by Site, STD Surveillance Network (SSuN), 2011

thumbnail of Figure 28Figure 28. Gonorrhea—Positivity Among Women Aged 15–24 Years Tested in Family Planning Clinics, by State, Infertility Prevention Project, United States and Outlying Areas, 2011

thumbnail of Figure 29Figure 29. Location of Participating Sentinel Sites and Regional Laboratories, Gonococcal Isolate Surveillance Project (GISP) United States, 2011

thumbnail of Figure 30Figure 30. Distribution of Minimum Inhibitory Concentrations (MICs) of Ceftriaxone Among Neisseria gonorrhoeae Isolates, Gonococcal Isolate Surveillance Project (GISP), 2007–2011

thumbnail of Figure 31Figure 31. Distribution of Minimum Inhibitory Concentrations (MICs) of Cefixime Among Neisseria gonorrhoeae Isolates, Gonococcal Isolate Surveillance Project (GISP) 2009–2011

thumbnail of Figure 32Figure 32. Distribution of Minimum Inhibitory Concentrations (MICs) of Azithromycin Among Neisseria gonorrhoeae Isolates, Gonococcal Isolate Surveillance Project (GISP) 2007–2011

thumbnail of Figure 33Figure 33. Percentage of Neisseria gonorrhoeae Isolates that are Cirpofloxacin-Resistant by Sex of Sex Partner, Gonococcal Isolate Surveillance Project (GISP) 1995–2011

thumbnail of Figure 34Figure 34. Penicillin, Tetracycline, and Ciprofloxacin Resistance Among Neisseria gonorrhoeae Isolates, Gonococcal Isolate Surveillance Project (GISP), 2011

thumbnail of Figure 35Figure 35. Antimicrobial Drugs Used to Treat Gonorrhea Among Participants, Gonococcal Isolate Surveillance Project (GISP)—1988–2011

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #